Breast Cancer. Malignant Neoplasm of Breast
Conditions
Interventions
Intervention 1: Beta Glucan 10 mg, 2 tablets a day 21 days. Intervention 2: Beta Glucan 10 mg, 2 tablets a day 21 days with Lactobacillus Rhamnosus GG (2*107 CFU) for 21 days. Intervention 3: Pla
Treatment - Other
Placebo
Beta Glucan 10 mg, 2 tablets a day 21 days
Beta Glucan 10 mg, 2 tablets a day 21 days with Lactobacillus Rhamnosus GG (2*107 CFU) for 21 days
Sponsors
Hematology Oncology Research Center, Tabbriz University of medical Sciences
Eligibility
Sex/Gender
Female
Age
20 Years to 70 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: physician definitive diagnosis of breast cancer; receiving chemotherapy; the ability to drink at least 100 ml of water per day; life expectancy and survival at least 3 months; no allergies to molds and yeasts; adequate bone marrow function; proper function of kidney; absence of other acute medical conditions and aged 20 years and older. Exclusion criteria: patient reluctance to participate in the study; pregnant women; lactating women and existence the acute medical illness.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement of Immune System. Timepoint: Immediately After the Intervention. Method of measurement: CBC,CD4,CD45,IL-4,IL-12. | — |
Secondary
| Measure | Time frame |
|---|---|
| Improved Chemotherapy Side Effects. Timepoint: Immediately After the Intervention. Method of measurement: Questionnair.;Improved Nutrition Status. Timepoint: Immediately After the Intervention. Method of measurement: Anthropometric Assessment. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNazila Farrin
Faculty of Nutrition, Tabriz University of Medical Sciences
Outcome results
None listed